Pantone's Colour of the Year for 2025 hasn't just caught the attention of interior designers — gardeners are jumping on the ...

https://www.tipranks.com/news/the-fly/akebia-announces-multiple-positive-business-updates Akebia (AKBA) Therapeutics announced multiple positive business updates. As ...

The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GSK’s Jesduvroq.

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report), retaining the price target of $7.50. Discover outperforming stocks and invest smarter ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) shareholders will doubtless be very grateful to see the share price up 31% in the last quarter. But spare a thought for the long term holders, who have held ...

CAMBRIDGE, Mass., Dec. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease ...

The FDA, which turned away Akebia's initial application last March 2022, has a target action of Wednesday on the company's resubmission, which included Explore Our Brands WSJ ...

Akebia (AKBA) Therapeutics announced multiple positive business updates. As of January, Vafseo tablets are available in the U.S. for adult patients with anemia due to chronic kidney disease on ...

Akebia received feedback from the U.S. Food and Drug Administration (FDA) on its protocol submission for a label expansion study and is incorporating feedback as appropriate. Akebia expects to begin ...

New Commercial Supply Contracts for Vafseo® (vadadustat) secured, bringing availability and dialysis organization coverage to nearly 100% of patients on dialysis in U.S. Akebia also announced its ...

CAMBRIDGE, Mass., Jan. 13, 2025 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease ...